butabarbital decreases consequences of sufentanil SL by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Modify Therapy/Monitor Closely. Coadministration of CYP3A4 inducers may possibly lessen sufentanil levels and efficacy, maybe precipitating withdrawal syndrome in individuals which have formulated Bodily dependence to sufentanil. Discontin